BioAgilytix Is Re-approved and Registered For The French Research Tax Credit (CIR)

The Latest News from BioAgilytix

Frank Horling, Ph.D. Joins BioAgilytix
6 May, 2020

Frank Horling, Ph.D. Joins BioAgilytix Leadership Team as General Manager, Europe

In this role, Dr. Horling will lead Operations, Finance, HR, and Facilities for BioAgilytix’s European business and its laboratory located in Hamburg, Germany.

Read More

BioAgilytix Expert: Jim McNally, Ph.D
29 April, 2020

BioAgilytix Welcomes Jim McNally, Ph.D. to Leadership Team as Chief Scientific Officer

Dr. McNally brings with him an extensive background in bioanalytical assay development and program leadership working for almost 20 years in the pharmaceutical and biotechnology industry.

Read More

Dominic Marasco - BioAgilytix - Bioanalytical Expert
12 December, 2019

BioAgilytix Welcomes Dominic Marasco to Leadership Team as Chief Commercial Officer

Mr. Marasco will provide strategic direction to BioAgilytix’s global business development and marketing functions / teams to further expand worldwide adoption of the company’s premier bioanalytical services.

Read More

Cambridge Biomedical is now a part of BioAgilytix
4 November, 2019

BioAgilytix Announces Acquisition of Boston-Based Clinical Research Organization Cambridge Biomedical

Cambridge Biomedical, a contract research organization based in the Cambridge area of Massachusetts, also specializes in large molecule bioanalysis. The transaction expands BioAgilytix’s global footprint into the heart of the world’s major biotech center, and adds further capacity by joining Cambridge Biomedical’s CLIA-certified, CAP-accredited, and GLP-compliant facility with its GxP laboratories in Durham, North Carolina and Hamburg, Germany.

Read More

BioAgilytix Receives Certificate of Registration from CLIA
22 October, 2019

BioAgilytix Receives Certificate of Registration from CLIA

BioAgilytix has received its Certificate of Registration from the Clinical Laboratory Improvement Amendments (CLIA) program regulated by the Centers for Medicare & Medicaid Services (CMS) for its U.S. facility in Durham, NC. The CLIA certificate confirms that BioAgilytix is now able to perform lab-developed tests in the diagnostic immunology specialty that are deemed “high complexity” and subject to CLIA oversight.

Read More

Fast 50 logo
14 October, 2019

BioAgilytix Named a Triangle Business Journal Fast 50 Winner for 2019

BioAgilytix has been named by Triangle Business Journal as a Fast 50 Award winner for 2019, marking the seventh time the organization has been recognized as one of the fastest growing privately held companies in the Triangle Park area.

Read More

Thomas Zajkowski, BioAgilytix Financial Leadership Team
15 August, 2019

Thomas Zajkowski Joins BioAgilytix Leadership Team as Chief Financial Officer

Mr. Zajkowski brings more than 25 years of experience managing finance functions in private equity-sponsored and publicly-traded companies, including multiple healthcare and life sciences organizations.

Read More

Inc. 5000 award
14 August, 2019

BioAgilytix Named to Inc. Magazine’s Inc. 5000 List of Fastest-Growing Private U.S. Companies for Sixth Time

BioAgilytix has been named to Inc. Magazine’s Inc. 5000 list of the fastest-growing private companies in America for 2019: its sixth appearance on the list in the last seven years.

Read More

BioAgilytix New Campus Expansion in the US
9 July, 2019

BioAgilytix Completes New Campus Expansion at Its USA Headquarters

BioAgilytix has completed the latest expansion of its Durham, NC campus, which serves as the company’s USA headquarters, with the opening of an additional 21,173 square foot building directly adjacent to its existing facility.

Read More